HPLC and Mass Spectrometry in Peptide Quality Documentation

Analytical documents for research peptides often include results from high-performance liquid chromatography (HPLC) and mass spectrometry (MS). These methods answer different questions. HPLC commonly evaluates chromatographic purity, while mass spectrometry helps confirm whether the measured molecular mass is consistent with the expected molecule. Neither result should be interpreted alone as complete proof of quality.

What HPLC can show

HPLC separates components according to their interaction with a stationary phase and a flowing mobile phase. The detector produces a chromatogram containing peaks at different retention times. Laboratories often report the area percentage of the principal peak as an estimate of chromatographic purity.

Purity is method-dependent

A reported value such as 98% or 99% is meaningful only in the context of the method. Column chemistry, gradient, solvents, detector wavelength, injection amount, integration settings, and sample preparation can influence the chromatogram. For a related sample-handling variable, see our guide to peptide adsorption to labware. A high area percentage does not automatically confirm identity, quantity, sterility, or the absence of every possible impurity.

Questions to ask about an HPLC result

• Is the sample or lot number clearly identified?
• Are the method and detector conditions described?
• Is the complete chromatogram available rather than only a percentage?
• Are retention time and peak integration visible?
• Was the analysis performed by the supplier or an independent laboratory?

What mass spectrometry can show

Mass spectrometry measures mass-to-charge ratios of ionised molecules. For peptides, a spectrum may contain several charge states. After interpretation or deconvolution, the observed mass can be compared with the theoretical mass expected from the sequence and any stated modification.

Identity support, not total characterisation

A matching molecular mass provides strong support for identity, but molecules with similar masses or certain sequence-related variants may require additional methods. Mass spectrometry also does not by itself establish how much material is present in the vial.

Questions to ask about an MS result

• Does the reported theoretical mass match the stated sequence and modification?
• Is the observed mass within the laboratory’s documented tolerance?
• Are raw or representative spectra included?
• Is the ionisation method identified?
• Does the report reference the same lot as the HPLC result?

Why HPLC and MS should be reviewed together

HPLC and MS are complementary. HPLC can indicate that one chromatographic component dominates the sample, while MS can show that a detected component has the expected molecular mass. Together they provide a more informative picture than either method alone, but additional testing may be needed depending on the intended research application.

For a complementary workflow, see our guide to reference standards and controls in peptide analysis.

Other documentation that may matter

A complete Certificate of Analysis may also include peptide content or assay, water content, residual solvents, counter-ion information, appearance, solubility notes, bioburden or endotoxin testing where relevant, and the analytical laboratory’s details. The required panel should be defined by the laboratory’s protocol and risk assessment.

Warning signs in analytical documentation

• Reports without a lot or batch reference
• Cropped chromatograms or spectra with missing axes
• Purity percentages without a method
• The same report reused for multiple lots
• Theoretical and observed mass values that are not reconciled
• Inconsistent product names, dates, or sample identifiers

A practical review workflow

1. Match the product, sequence, modification, and lot across every document.
2. Review the HPLC chromatogram and method context.
3. Compare theoretical and observed mass in the MS report.
4. Check whether quantity and other specifications require separate tests.
5. Record reviewer, date, findings, and any unresolved questions.

Conclusion

HPLC and mass spectrometry provide valuable but distinct information. Strong peptide documentation clearly links both results to the same lot, describes the methods used, and avoids treating a single purity number as complete proof of quality. These records should be reviewed together with the COA, specifications, packaging, storage history, and any application-specific requirements.

For laboratory research and educational purposes only. Not for human consumption or medical use.

Product documentation enquiries

For product-specific specifications and available batch documentation, consult these catalogue pages. The analytical approach must be selected for the particular material; these links do not imply that every listed product uses an identical assay.

• Retatrutide 20 mg
• MOTS-c
• GHK-Cu
• SLU-PP-332
• AOD-9604
• BBG
• BBG 70 / GLOW 70
• Follistatin 1 mg